Wegovy Coupon: What the Manufacturer Savings Card Covers

What the Wegovy label covers

Wegovy is Novo Nordisk's semaglutide product approved for chronic weight management [2][1]. Its prescribing information covers the drug itself: indications, dosing, warnings, adverse reactions and interactions [1]. It describes Wegovy dosing, and it does not list a savings-card discount, eligibility rules or limits [1].

Which Wegovy products exist

Wegovy injection was approved on 2021-06-04 under NDA 215256 [2]. The label covers three uses, each alongside a reduced-calorie diet and more physical activity:

• reducing the risk of major cardiovascular events in adults with established cardiovascular disease and either obesity or overweight;
• reducing excess body weight and maintaining the loss in adults and children aged 12 and older with obesity, and in adults with overweight plus at least one weight-related condition;
• treating noncirrhotic MASH with moderate to advanced fibrosis (stages F2 to F3) in adults, under accelerated approval [1].

Wegovy tablets are a separate approval, granted 2025-12-22, and are for adults only: cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight, and weight reduction in adults with obesity or with overweight plus a related condition. The tablet label gives no pediatric or MASH indication [3][1].

Ozempic is a different semaglutide product from the same company, approved for type 2 diabetes and with no weight-loss indication [5].

Compounded semaglutide is not the brand

A compounded semaglutide prescription is not a Wegovy prescription. FDA says compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before marketing [4]. The Wegovy label also says the drug is not recommended in combination with another semaglutide-containing product or with any other GLP-1 receptor agonist [1].